The Antisocial Doctors Podcast

Sonia Singh MD & Rebecca Berens MD

Join Dr. Rebecca Berens & Dr. Sonia Singh as they unpack viral health trends with curiosity, nuance, and compassion. No snark, no shame —just thoughtful conversations about what’s true, what’s hype, why we're drawn to it and how to find calm and clarity in the chaos of social media and online health advice.

  1. 10h ago

    Episode 16: Why Is PCOS Now Called PMOS?

    In this episode, we talk about the viral name change from PCOS to PMOS and why it’s sparking so much conversation online. We share why this shift feels validating for so many people who’ve struggled for years to get clear answers, and we unpack the kinds of confusing, oversimplified claims that flood social media around this condition. We also explore why the name change matters beyond semantics, what concerns some patients have about it, and what we wish more people understood before falling into the “cure” and “root cause” rabbit holes. 00:00 Podcast intro 01:20 Episode topic reveal 02:02 Patient diagnosis delays 03:38 Sonia personal story 07:16 Social media claims 09:36 Why it went viral 15:28 Nugget of truth 17:51 Backlash and concerns 22:11 Defining and diagnosing 22:33 Rotterdam criteria 30:09 Ruling out other causes 32:54 PCOS subtypes explained 41:34 Biomarkers and testing 46:19 CRP Inflammation Confusion 48:13 Metabolic Biomarkers Breakdown 49:21 Vitamin D Iron Testing Debate 52:38 Guidelines and Sleep Apnea Risk 54:49 Birth Control Not a Band Aid 01:01:15 Fertility Timing and REI Referral 01:03:38 Lifestyle Basics Fiber Exercise Sleep 01:08:50 Medications Metformin to GLP1s 01:16:18 Weight Stigma Habits Over Pounds 01:20:34 Who Should Manage PCOS Care 01:24:32 How to Talk to Patients 01:27:35 Resources Wrap Up Disclaimer 📖 Read the full episode summary, sources, and resources on our Substack:  👉www.theantisocialdoctors.com

    1h 30m
  2. May 14

    Episode 13: Are GLP-1s a Miracle, a Mistake, or Something More Complicated?

    In this episode, we dive into the GLP-1 conversation that’s everywhere—between “miracle drug” hype, scary side-effect stories, and the stigma that comes with seeking help. We share the kind of patient scenario we’re seeing constantly, talk about why these meds went viral, and explore what often gets lost in online discourse: nuance, individualized risk/benefit decisions, and real informed consent. We also tease what we consider when someone has health anxiety, a history of disordered eating, or is getting information (or prescriptions) through less-regulated channels.  00:00 Podcast intro and mission 01:18 Patient story GLP-1 dilemma 03:23 Social media claims and stigma 06:29 Why GLP-1s went viral 12:06 Nugget of truth and nuance 13:51 What GLP-1 drugs are 17:57 Benefits beyond diabetes 23:57 Fatty liver and metabolism 28:37 Is weight loss a benefit 34:22 Weight Stigma in Care 35:53 When to Discuss Weight 37:46 Is Weight Loss a Benefit 39:05 BMI vs Metabolic Health 40:21 GLP-1 Weight Loss Data 43:31 Long-Term Outcomes Matter 44:53 Weight Cycling Risks 47:58 Other Potential Benefits 48:51 Common Side Effects 49:59 Muscle and Bone Loss 52:44 Cancer and Eye Concerns 56:13 Mental Health Signals 59:21 Telehealth Misuse Risks 01:02:45 Cost and Sustainability 01:05:23 Alternatives Like Metformin 01:06:29 Long-Term Treatment Reality 01:09:37 Undereating Risks 01:10:04 Early Intervention Debate 01:11:12 Biology Over Willpower 01:11:58 Environment Versus Meds 01:13:58 Weight Cycling Reality 01:15:31 Compounded GLP-1 Dangers 01:21:05 Informed Consent Lessons 01:22:42 Stigma and Patient Fears 01:27:08 Food Noise Explained 01:31:40 Fatphobia and Epigenetics 01:35:05 How We Counsel Patients 01:43:01 Resources and Disclaimer 📖 Read the full episode summary, sources, and resources on our Substack:  👉www.theantisocialdoctors.com

    1h 45m
  3. Apr 29

    Episode 12: What's the Deal With Peptides?

    In this episode, we dig into peptides—why they’re suddenly everywhere, why people are trying them, and why the online conversation often feels worlds apart from the medical one. We zoom out from the hype to explore what peptides actually are, why some have become blockbuster therapies, and how a mix of optimization culture, mistrust of institutions, and access issues has fueled a booming gray market. We also explore the key questions we think everyone should be asking before trying anything that’s framed as “natural,” “risk-free,” or “not really a drug,” and we discuss what this trend can teach us about informed consent, patient autonomy, and where medicine may be headed next. 00:00 Podcast intro 01:18 Meet the hosts 01:21 Peptides topic setup 02:01 Patient longevity story 03:39 Why peptides hype 05:11 Natural fallacy talk 06:50 What is a peptide 08:19 Peptide drugs history 10:47 Why peptides booming 12:06 Legal gray areas 13:55 Why it went viral 14:50 Optimization culture 16:35 Distrust and marketing 20:14 K shaped economy angle 24:37 Nugget of truth 26:44 Peptides are drugs 28:56 Gray market risks 31:30 Evidence categories 32:49 FDA approved examples 33:22 Immune booster peptide 34:14 Growth Hormone Peptides 35:00 Side Effects Reality Check 36:49 Statins Versus Hype 37:54 Retatrutide Triple Agonist 38:59 Wolverine Stack Breakdown 39:31 BPC 157 Claims 40:35 TB 500 No Human Data 43:17 Regulation Versus Wild West 45:11 Why Patients Take Risks 46:42 Doctoring With Empathy 50:26 Informed Consent Gaps 52:55 Framing Changes Decisions 55:39 Peptides Future Outlook 58:26 Fund Studies Faster 01:00:05 Wrap Up And Disclaimer 📖 Read the full episode summary, sources, and resources on our Substack:  👉www.theantisocialdoctors.com

    1h 2m
5
out of 5
11 Ratings

About

Join Dr. Rebecca Berens & Dr. Sonia Singh as they unpack viral health trends with curiosity, nuance, and compassion. No snark, no shame —just thoughtful conversations about what’s true, what’s hype, why we're drawn to it and how to find calm and clarity in the chaos of social media and online health advice.

You Might Also Like